Cigna's Evernorth Health Services said on Wednesday its actions will enhance transparency about the company's negotiations.

In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus.

It’s the latest step from pharmacy benefit managers to respond to relentless criticism from politicians and regulators over ...

However, its low valuation could have investors wondering if now is the right time to take a chance on the business, ...

CVS has launched a new all-in-one app for its pharmaceutical and retail services. Someday you may be able to use it to open ...

The company said the unlocking function, part of a pilot program in New York City, will be expanded this year.

CVS Health is launching an app that will allow customers access to locked display cabinets "for easier access to merchandise, ...

After UnitedHealthcare CEO Brian Thompson was shot to death in December, law enforcement records show a burst of police ...

TD Cowen analyst Ryan Langston maintained a Buy rating on Cigna (CI – Research Report) today and set a price target of $391.00. The company’s ...